VR Adviser as of Dec. 31, 2023
Portfolio Holdings for VR Adviser
VR Adviser holds 36 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rayzebio | 17.2 | $251M | 4.0M | 62.17 | |
| Apogee Therapeutics (APGE) | 16.3 | $237M | 8.5M | 27.94 | |
| Pharvaris N V (PHVS) | 6.5 | $95M | 3.4M | 28.05 | |
| Miragen Therapeutics (VRDN) | 5.8 | $85M | 3.9M | 21.78 | |
| 4d Molecular Therapeutics In (FDMT) | 4.8 | $69M | 3.4M | 20.26 | |
| Merus N V (MRUS) | 4.1 | $59M | 2.1M | 27.50 | |
| Cabaletta Bio (CABA) | 4.0 | $58M | 2.6M | 22.70 | |
| Spyre Therapeutics Com New (SYRE) | 3.5 | $51M | 2.4M | 21.52 | |
| Kalvista Pharmaceuticals (KALV) | 3.4 | $50M | 4.1M | 12.25 | |
| Enliven Therapeutics (ELVN) | 2.8 | $41M | 3.0M | 13.84 | |
| Ocular Therapeutix (OCUL) | 2.4 | $35M | 7.8M | 4.46 | |
| Hillevax (HLVX) | 2.3 | $33M | 2.1M | 16.05 | |
| Ambrx Biopharma | 2.0 | $30M | 2.1M | 14.24 | |
| Terns Pharmaceuticals (TERN) | 2.0 | $29M | 4.5M | 6.49 | |
| Dyne Therapeutics (DYN) | 2.0 | $29M | 2.2M | 13.30 | |
| Cogent Biosciences (COGT) | 1.9 | $28M | 4.7M | 5.88 | |
| Celcuity (CELC) | 1.9 | $28M | 1.9M | 14.57 | |
| Mersana Therapeutics (MRSN) | 1.8 | $26M | 11M | 2.32 | |
| Arvinas Ord (ARVN) | 1.8 | $26M | 628k | 41.16 | |
| Astria Therapeutics (ATXS) | 1.7 | $25M | 3.2M | 7.68 | |
| Rhythm Pharmaceuticals (RYTM) | 1.6 | $23M | 496k | 45.97 | |
| Oric Pharmaceuticals (ORIC) | 1.5 | $22M | 2.4M | 9.20 | |
| Applied Therapeutics (APLT) | 1.4 | $21M | 6.3M | 3.35 | |
| Taysha Gene Therapies Com Shs (TSHA) | 1.3 | $18M | 10M | 1.77 | |
| Savara (SVRA) | 1.1 | $17M | 3.5M | 4.70 | |
| Lyra Therapeutics (LYRA) | 0.9 | $14M | 2.6M | 5.24 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.7 | $11M | 999k | 10.70 | |
| Dianthus Therapeutics (DNTH) | 0.7 | $9.6M | 928k | 10.40 | |
| Praxis Precision Medicines I Com New (PRAX) | 0.5 | $7.9M | 354k | 22.28 | |
| Gh Research Ordinary Shares (GHRS) | 0.5 | $7.6M | 1.3M | 5.80 | |
| Acelyrin (SLRN) | 0.5 | $7.0M | 937k | 7.46 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.4 | $5.8M | 250k | 23.11 | |
| Trevi Therapeutics (TRVI) | 0.3 | $4.6M | 3.4M | 1.34 | |
| Adverum Biotechnologies | 0.3 | $3.9M | 5.1M | 0.75 | |
| Milestone Pharmaceuticals (MIST) | 0.1 | $1.5M | 925k | 1.67 | |
| Olema Pharmaceuticals (OLMA) | 0.1 | $1.1M | 77k | 14.03 |
